Cite
HARVARD Citation
Mullen, M. et al. (2019). Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Lancet. 394 (10216), pp. 2263-2270. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mullen, M. et al. (2019). Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Lancet. 394 (10216), pp. 2263-2270. [Online].